Difference between revisions of "Sunitinib"
Jump to navigation
Jump to search
(create) |
|||
| Line 1: | Line 1: | ||
'''Sunitinib''' is a [[tyrosine kinase inhibitor]] used to treat [[renal cell carcinoma]] (RCC). | '''Sunitinib''' (marketed with the brand name ''Sutent'') is a [[tyrosine kinase inhibitor]] used to treat [[renal cell carcinoma]] (RCC). | ||
In RCC acts on:<ref>{{Cite journal | last1 = Toon | first1 = CW. | last2 = Hasovits | first2 = C. | last3 = Paik | first3 = J. | last4 = Field | first4 = M. | last5 = Chou | first5 = A. | last6 = Hugh | first6 = TJ. | last7 = Pavlakis | first7 = N. | last8 = Gill | first8 = AJ. | title = Skin rash, a kidney mass and a family mystery dating back to World War II. | journal = Med J Aust | volume = 201 | issue = 1 | pages = 58-60 | month = Jul | year = 2014 | doi = | PMID = 24999901 }}</ref> | In RCC acts on:<ref>{{Cite journal | last1 = Toon | first1 = CW. | last2 = Hasovits | first2 = C. | last3 = Paik | first3 = J. | last4 = Field | first4 = M. | last5 = Chou | first5 = A. | last6 = Hugh | first6 = TJ. | last7 = Pavlakis | first7 = N. | last8 = Gill | first8 = AJ. | title = Skin rash, a kidney mass and a family mystery dating back to World War II. | journal = Med J Aust | volume = 201 | issue = 1 | pages = 58-60 | month = Jul | year = 2014 | doi = | PMID = 24999901 }}</ref> | ||
| Line 10: | Line 10: | ||
==References== | ==References== | ||
{{Reflist|1}} | {{Reflist|1}} | ||
[[Category: Clinical]] | |||
Revision as of 15:07, 20 October 2014
Sunitinib (marketed with the brand name Sutent) is a tyrosine kinase inhibitor used to treat renal cell carcinoma (RCC).
In RCC acts on:[1]
- VEGF.
- PDGFbeta.